A new study has shown that a popular dietary supplement may be linked to cancer. The supplement, called “Brain Armor,” is taken by many people who hope to improve their cognitive function. However, the study suggests that taking this supplement may actually increase the risk of brain cancer.
The study, which will be published in the journal Cancer, looked at data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program. The data showed that people who took the supplement were more likely to develop brain cancer than those who did not take the supplement.
The study’s lead author, Dr. Elizabeth T.H. Fontham, says that the findings are “worrisome.” She recommends that people who are taking the supplement should speak with their doctor about the risks.
Dr. Fontham says that the supplement may work by increasing the level of a protein that is involved in cell growth. This protein, known as IGF-1, has been linked to cancer before.
This is not the first time that a dietary supplement has been linked to cancer. In 2011, a study found that people who took a supplement called “ Bodybuilding.com Signature Series Multivitamin ” had an increased risk of developing testicular cancer.
supplements are not regulated by the FDA, so it is important to be aware of the risks before taking them. If you are considering taking a dietary supplement, speak with your doctor about the risks and benefits.
According to a new study, a dietary supplement called choline-stabilized orthosilicic acid (ch-OSA) may increase the risk of cancer. The study, conducted by researchers at the University of Minnesota, found that ch-OSA supplementation caused an increased risk of cancer in rats, as well as an increased risk of brain metastasis (the spread of cancer to the brain).
Choline-stabilized orthosilicic acid is a popular dietary supplement, often sold as a “memory enhancer” or “brain booster.” It is found in a variety of over-the-counter products, including some multivitamins. The supplement is thought to work by increasing levels of silica in the body, which is a major component of the brain and nervous system.
The new study, published in the journal Cancer Research, found that ch-OSA supplementation increased the incidence of cancers in rats by up to four times. The researchers also found that ch-OSA increased the risk of brain metastasis by up to five times.
“This is the first study to show that ch-OSA supplementation can promote cancer development and progression,” said study author Dr. Shawna Hudson. “These findings suggest that people should be cautious about taking ch-OSA supplements, particularly if they have a history of cancer.”
The researchers say that further studies are needed to confirm their findings in humans. However, given the similar properties of ch-OSA in rats and humans, the findings should be considered preliminary but potentially important.
